Clinical Trial Update: The Efficacy and Safety of Tofacitinib in Patients With Glucocorticoid Resistant ICIs-related Myocarditis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of tofacitinib in patients with glucocorticoid-resistant immune checkpoint inhibitor-related myocardit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Checkpoint Inhibitor-related Myocarditis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Glucocorticoid Resistant ICIs-related Myocarditis | Phase 2 | Status: NOT_YET_RECRUITING